BioInsights - Scaling non-viral cell therapy approaches for solid tumor treatments

Scaling non-viral cell therapy approaches for solid tumor treatments

DOI: 10.18609/cgti.2022.128

Cell & Gene Therapy Insights 2022; 8(8), 835

Published: 6 September 2022
Evan Zynda, PhD, Nektaria Andronikou


 The need for standardization and high manufacturing success rates are critical drivers of innovation in cell therapy. Thermo Fisher Scientific has built a fit-for-purpose portfolio of modular instrumentation platforms designed to support closed, large-scale cell therapy manufacturing — enabling automation of the end-to-end manufacturing workflow.